Ascletis
North America, North Carolina, United States, Chapel Hill
Description
Ascletis is a specialty therapeutics company developing therapeutics for the treatment of cancer and infectious diseases.
Investor Profile
Ascletis has backed more than 3 startups, with 0 new investments in the last 12 months alone. The firm has led 2 rounds, about 67% of its total and boasts 1 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series E, Series Unknown rounds (top funding stages).
- Majority of deals are located in United States.
- Strong thematic focus on Biopharma, Biotechnology, Therapeutics.
Stage Focus
- Series E (67%)
- Series Unknown (33%)
Country Focus
- United States (100%)
Industry Focus
- Biopharma
- Biotechnology
- Therapeutics
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
